快速診斷市場規模、佔有率和成長分析（按產品、平台、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，快速診斷市場規模將達到 441.2 億美元，到 2025 年將達到 534.7 億美元，到 2033 年將達到 2489.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 21.2%。

全球感染疾病和慢性病的日益流行，以及對更高品質診斷解決方案需求的不斷成長，預計將推動快速診斷市場的發展。對創新診斷技術的大量投資有望為該領域的營運商開闢新的機會。此外，即時檢測的廣泛應用以及人們對家庭診斷日益成長的興趣，也可能進一步推動市場成長。政府旨在意識提升和推進快速檢測調查方法的舉措，預計也將對快速診斷公司的收入產生積極影響。然而，高昂的產品成本、熟練專業人員短缺、嚴格的法規結構以及供應鏈限制等挑戰，可能會阻礙快速診斷的廣泛應用。

快速診斷市場促進因素

全球感染疾病率的不斷上升推動了對更先進診斷方法的需求。快速診斷檢測能夠及早發現這些疾病，有助於在早期階段有效預防大規模疫情爆發。這種快速檢測感染疾病的能力在降低大規模流行病的風險方面發揮關鍵作用。此外，人們對感染疾病的認知不斷提高，以及對及時診斷重要性的認知不斷增強，也推動了對快速診斷解決方案的需求。因此，快速診斷市場正在經歷顯著成長，以滿足應對感染疾病威脅所需的高效醫療解決方案的迫切需求。

快速診斷市場的限制因素

由於政府機構和監管機構的嚴格規定，快速診斷市場面臨巨大的挑戰。這些規定要求提供全面的文件和詳盡的測試通訊協定。這種嚴苛的合規流程可能會為該領域的企業帶來許多不便，導致延誤，並阻礙其快速將創新產品推向市場。因此，這些監管障礙可能會減緩整個快速診斷市場的成長前景，並使企業難以順利通過核准流程，最終影響企業的營運效率和市場動態。

快速診斷市場趨勢

將人工智慧 (AI) 應用於快速診斷正成為一項關鍵的市場趨勢，它將顯著提高疾病檢測的準確性和效率。企業採用 AI 技術為預測分析開闢了道路，從而能夠更早診斷各種健康狀況。醫療保健行業的快速數位化進一步加速了這一趨勢，簡化了流程並推動了診斷解決方案的創新。隨著相關人員適應這些進步，對 AI 驅動的診斷工具的需求預計將會成長，使其成為個人化醫療的重要組成部分，並在不斷變化的醫療保健環境中改善患者的治療效果。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球快速診斷市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 傳染病檢查
  • 呼吸道傳染病檢查產品
  • 流感
  • 肝炎
  • HIV
  • 其他傳染病檢查
• 血糖監測
• 心血管代謝檢測
• 血液凝固檢驗產品
• 妊娠和不孕症檢查
• 腫瘤/癌症標記檢測產品
• 尿液檢查產品
• 膽固醇檢測產品
• 血液檢測產品
• 藥物濫用檢測產品
• 大便潛血試驗產品
• 其他產品

全球快速診斷市場規模（按購買類型和複合年成長率分類）（2026-2033 年）

• OTC
• 基於處方箋的檢測

全球快速診斷市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 流通式
• 固相法
• 側向流
• 凝集反應
• 其他技術

全球快速診斷市場規模（按分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 實體店面
• 電子商務
• 其他分銷管道

全球快速診斷市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 診斷中心
• 居家醫療環境
• 醫院藥房
• 其他最終用戶

全球快速診斷市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Danaher（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• QuidelOrtho（USA）
• Bio-Rad Laboratories（USA）
• Hologic（USA）
• Cepheid（USA）
• Ortho Clinical Diagnostics（USA）
• Siemens Healthineers（Germany）
• Sysmex（Japan）
• Fujifilm Holdings（Japan）
• DiaSorin（Italy）
• BioMerieux（France）
• Instrumentation Laboratory（USA）

結論與建議

Rapid Diagnostics Market size was valued at USD 44.12 Billion in 2024 and is poised to grow from USD 53.47 Billion in 2025 to USD 248.98 Billion by 2033, growing at a CAGR of 21.2% during the forecast period (2026-2033).

The increasing prevalence of infectious and chronic diseases globally, coupled with a rising demand for superior diagnostic solutions, is anticipated to propel the rapid diagnostics market. Significant investments in innovative diagnostic technologies promise to unlock new avenues for providers in this sector. Furthermore, the growing trend of point-of-care testing and the heightened interest in home-based diagnostics are likely to further drive market growth. Government initiatives aimed at enhancing awareness of early detection and advancing rapid testing methodologies are also projected to contribute positively to revenue streams for rapid diagnostics companies. However, challenges such as high product costs, a shortage of skilled professionals, stringent regulatory frameworks, and supply chain limitations may hinder the widespread adoption of rapid diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Diagnostics Market Segments Analysis

Global Rapid Diagnostics Market is segmented by Product, Purchase, Technology, Distribution Channel, End Use and region. Based on Product, the market is segmented into Infectious Disease Testing, Glucose Monitoring,Cardiometabolic Exercise Testing, Coagulation Testing Products, Pregnancy And Fertility Testing, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Fecal Occult Testing Products and Other Products. Based on Purchase, the market is segmented into OTC and Prescription-Based Tests. Based on Technology, the market is segmented into Flow-Through, Solid Phase, Lateral Flow, Agglutination Assays and Other Technologies. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Brick & Mortar, E-Commerce and Other Distribution Channels. Based on End Use, the market is segmented into Diagnostic Centers, Homecare Settings, Hospital Pharmacies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Rapid Diagnostics Market

The growing incidence of infectious diseases globally has led to an escalating demand for improved diagnostic methods. Rapid diagnostic tests facilitate the early identification of these diseases, effectively aiding in the prevention of widespread outbreaks during their initial phases. This ability to swiftly detect infections plays a crucial role in mitigating the risk of large-scale pandemics. Additionally, the increasing awareness surrounding infectious diseases and the importance of timely diagnosis is driving the demand for rapid diagnostic solutions. As a result, the rapid diagnostics market is experiencing significant growth, responding to the urgent need for efficient healthcare solutions in addressing infectious threats.

Restraints in the Rapid Diagnostics Market

The rapid diagnostics market faces significant challenges due to stringent regulations imposed by governmental bodies and regulatory authorities, which require comprehensive documentation and extensive testing protocols. This rigorous compliance process can be cumbersome for companies in the field, resulting in delays and hindering their ability to bring innovations to market swiftly. As a result, these regulatory hurdles may dampen the overall growth prospects of the rapid diagnostics market, making it difficult for companies to navigate the approval landscape and ultimately affecting their operational efficiency and market dynamics.

Market Trends of the Rapid Diagnostics Market

The integration of artificial intelligence in rapid diagnostics is emerging as a pivotal market trend, significantly enhancing both accuracy and efficiency in disease detection. As companies harness AI technologies, they unlock opportunities for predictive analytics, enabling earlier diagnosis of various health conditions. This trend is further fueled by the rapid digitization of the healthcare landscape, which is streamlining processes and driving innovation in diagnostic solutions. As stakeholders adapt to these advancements, the demand for AI-powered diagnostic tools is likely to grow, positioning them as essential components in personalized medicine and improving patient outcomes in a dynamic healthcare environment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Rapid Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
  • Respiratory Infection Testing Products
  • Influenza
  • Hepatitis
  • HIV
  • Other Infectious Disease Tests
• Glucose Monitoring
• Cardiometabolic Testing
• Coagulation Testing Products
• Pregnancy And Fertility Testing
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drug-Of-Abuse (DOA) Testing Products
• Fecal Occult Testing Products
• Other Products

Global Rapid Diagnostics Market Size by Purchase & CAGR (2026-2033)

• Market Overview
• OTC
• Prescription-Based Tests

Global Rapid Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Flow-Through
• Solid Phase
• Lateral Flow
• Agglutination Assays
• Other Technologies

Global Rapid Diagnostics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Brick & Mortar
• E-Commerce
• Other Distribution Channels

Global Rapid Diagnostics Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users

Global Rapid Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Purchase, Technology, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Product, Purchase, Technology, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Purchase, Technology, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Purchase, Technology, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Purchase, Technology, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations